Sign in
4

Changes in Ownership

PALVELLA THERAPEUTICS, INC. Filed Acc 0001104659-26-018136

Chief Operating Officer sold 4,302 shares at an average $79.40 ($341,564)

  • Chief Operating Officer acquired 4,302 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goin Kathleen · Chief Operating Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-18 Exercise or conversion : show line 1 in the form 10b5-1 +2,154 $7.14 $15,380 2,154 D
2026-02-18 Exercise or conversion : show line 2 in the form 10b5-1 +2,148 $9.08 $19,504 4,302 D
2026-02-18 Sale : show line 3 in the form 10b5-1 −3,026 $79.16 $239,529 1,276 D
2026-02-18 Sale : show line 4 in the form 10b5-1 −1,276 $79.97 $102,035 0 D
Open-market sales · 4,302 sh · avg $79.40 · $341,564

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-18 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −2,154 17,243 D
2026-02-18 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −2,148 17,184 D
Loading xslF345X05/tm266892-1_4seq1.xml…